Acalabrutinib/Obinutuzumab Regimen

Preferred Label : Acalabrutinib/Obinutuzumab Regimen;

NCIt synonyms : Calquence/Gazyva; Acalabrutinib-Obinutuzumab; Acalabrutinib-Obinutuzumab Regimen; Acalabrutinib/Obinutuzumab; Obinutuzumab Plus Acalabrutinib; Obinutuzumab/Acalabrutinib; Obinutuzumab/Acalabrutinib Regimen; Obinutuzumab-Acalabrutinib;

NCIt related terms : Acalabrutinib and Obinutuzumab;

NCIt definition : A regimen consisting of acalabrutinib and obinutuzumab that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;

NCI Metathesaurus CUI : CL1664362;

Codes from synonyms : 1354;

Details

Origin ID

C181198;

UMLS CUI

C5556899;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Acalabrutinib [NCIt concept]
- Obinutuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients